| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2323027
Max Phase: Preclinical
Molecular Formula: C18H15N
Molecular Weight: 245.32
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccc2nc(/C=C/c3ccccc3)ccc2c1
Standard InChI: InChI=1S/C18H15N/c1-14-7-12-18-16(13-14)9-11-17(19-18)10-8-15-5-3-2-4-6-15/h2-13H,1H3/b10-8+
Standard InChI Key: BRPDMIKQCQDAFG-CSKARUKUSA-N
Associated Targets(Human)
Amyloid-beta A4 protein 8510 Activities
Associated Targets(non-human)
Prion protein 315 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 245.32 | Molecular Weight (Monoisotopic): 245.1204 | AlogP: 4.71 | #Rotatable Bonds: 2 |
| Polar Surface Area: 12.89 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.16 | CX LogP: 5.22 | CX LogD: 5.22 |
| Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.64 | Np Likeness Score: -0.72 |
References
| 1. Staderini M, Aulić S, Bartolini M, Tran HN, González-Ruiz V, Pérez DI, Cabezas N, Martínez A, Martín MA, Andrisano V, Legname G, Menéndez JC, Bolognesi ML.. (2013) A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases., 4 (2): [PMID:24900645] [10.1021/ml3003605] |
Source
Source(1):